Phase 3 Development Program of Novel Selective Estrogen Receptor Modulator (SERM) Represents Potential Multi-Billion Dollar Opportunity as ...

PLT012, a groundbreaking anti-CD36 antibody, enters clinical trials to enhance immune responses in solid tumors, promising ...

Ragnhild Langli (70) is the first person in Norway to receive personalized chemotherapy for bowel cancer. She is ...

Adagene jumps 13.8% after the FDA grants Fast Track Status to muzastotug with pembrolizumab for MSS metastatic colorectal cancer.

Targeted radioactive implants combined with chemotherapy are transforming inoperable pancreatic cancer into surgical ...

The patient had been experiencing a wide range of obesity-related health issues, including difficulty in breathing, severe ...

What will be the next blockbuster research to emerge from Princeton’s labs? No one can say for sure, but history tells us ...

Aging taps us on the shoulder in many ways: wrinkles, thinning hair, loss of flexibility, slowing of the brain. But the ...

The CDC adopted controversial guidance from its advisory panel, ending recommendations for the Hepatitis B vaccine for all ...

Designation underscores the potential of SAFEbody®-enabled anti-CTLA-4 therapy to address unmet need in MSS colorectal ...

For patients living with HER2-positive metastatic breast cancer, the recent FDA approval of trastuzumab deruxtecan (brand ...

The patient received trifluridine/tipiracil plus bevacizumab as third-line therapy; is currently on month 4 of treatment.​ ...